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E-mail address: boazt@ekmd.huji.ac.il (B. Tirosh).The non-canonical splicing of XBP-1 mRNA is a hallmark of the mammalian unfolded protein
response (UPR). The proteasomal degradation of unspliced XBP-1 (XBP-1u) facilitates the termina-
tion of the UPR. Thus, understanding the mechanism of XBP-1u degradation may allow control over
UPR duration and intensity.
We show that XBP-1u interacts with puriﬁed 20S proteasomes through its unstructured C-terminus,
which leads to its degradation in a manner that autonomously opens the proteasome gate. In living
cells, the C-terminus of XBP-1u accumulates in aggresome structures in the presence of proteasome
inhibitors. We propose that direct proteasomal degradation of XBP-1u prevents its intracellular
aggregation.
Structured summary:
MINT-7302217: XBP1-u (uniprotkb:P17861-1) binds (MI:0407) to Proteasome subunit alpha 7.2 (uni-
protkb:O14818) by pull down (MI:0096)
MINT-7302148: Vimentin (uniprotkb:P08670) and XBP1-u (uniprotkb:P17861-1) colocalize (MI:0403) by
ﬂuorescence microscopy (MI:0416)
MINT-7302163: XBP1-u (uniprotkb:P17861-1) binds (MI:0407) to Proteasome subunit alpha 5 (uni-
protkb:P28066) by pull down (MI:0096)
MINT-7302186: XBP1-u (uniprotkb:P17861-1) binds (MI:0407) to Proteasome subunit alpha 6 (uni-
protkb:P60900) by pull down (MI:0096)
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction Themammalian UPR is composed of three transducers: PKR-likeThe endoplasmic reticulum (ER) is the port of entry of proteins
into the secretory pathway. Eukaryotic cells developed mecha-
nisms to adjust the amount of secretory pathway components to
meet the cellular demand. This is driven by conditions of ER stress,
which ensue when the amount of client proteins that emerge into
the ER exceeds its overall folding capacity. ER stress in eukaryotic
cells activates an intricate ER-to-nucleus signaling cascade that is
collectively termed the unfolded protein response (UPR) [1], which
is required for normal embryonic development [2–4], and its dys-
regulation in adulthood may cause a wide range of disorders [5–9].chemical Societies. Published by E
ATF6, activating transcription
armacy, The Hebrew Univer-
2 2 6758741.ER eIF2a kinase (PERK), activating transcription factor 6 (ATF6) and
inositol requiring enzyme 1 (IRE1). While the PERK and ATF6 path-
ways are unique to mammalian cells, the IRE1 pathway is
conserved among all metazoans. Upon ER stress, IRE1 cleaves the
mRNAof X-box-binding protein 1 (XBP-1). This non-canonical splic-
ing converts the unspliced XBP-1 (XBP-1u) into the spliced form
(XBP-1s) [10–12]. XBP-1s is a potent transcription factor that pro-
motes the transcription of a large number of target genes [13–15].
In yeast, the orthologue of XBP-1, Hac1, is not translated in its
unspliced form [16]. XBP-1u, however, is constantly generated,
but undergoes rapid proteasomal degradation [10,11], which limit
its biological signiﬁcance. Nonetheless, several roles for XBP-1u
have been proposed. In Caenorhabditis elegans XBP-1u has a direct
role in transcription [15]. In mammalian cells, XBP-1u serves as a
positive and negative modulator of the UPR. On the one hand it
promotes the targeting of its own mRNA to the ER membrane,
which facilitates the encounter with IRE1 and accelerates thelsevier B.V. All rights reserved.
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mal degradation of ATF6 and XBP-1s. XBP-1u shuttles between
the nucleus and cytoplasm [18]. It was demonstrated that XBP-
1u heterodimerizes with XBP-1s or ATF6 in the nucleus, which al-
lows the subsequent trafﬁcking of the dimer to the cytoplasm
where it undergoes degradation as a complex [18,19].
We previously showed that the C-terminus of XBP-1u (XBP-
1CTu) acts as a potent degron when appended onto otherwise stable
proteins, such as GFP or a HA-tag concatamer [20]. Our data in-
ferred that this proteasomal degradation may not require its prior
ubiquitination, however no direct evidence was provided.
Here, we directly addressed the requirement of ubiquitination
for XBP-1u degradation in vitro. Our data show that XBP-1CTu, but
not its N-terminus (the domain shared by XBP-1u and XBP-1s,
referred to as XBP-1NT), interacts with, the 20S proteasomes and
undergoes degradation. Interestingly, in living cells, upon protea-
some inhibition, XBP-1u has a strong propensity to aggregate and
accumulates in the aggresome. We propose that direct proteasomal
degradation may be a preemptive measure against XBP-1u
aggregation.2. Materials and methods
2.1. Cells and reagents
293T cells were maintained in DMEM (10% FCS, 2 mM gluta-
mine, 50 U/mL penicillin and 50 lg/mL of streptomycin). Cells were
transfected using standard calcium phosphate precipitation proto-
col. ZL3VS was kindly provided by Dr. Hidde Ploegh (WIBR, MA).
Anti-His tag antibodies were purchased from Santa Cruz biotech-
nology. 20S and 26S proteasomes were puriﬁed from rabbit muscle.
2.2. Degradation of XBP-1 by the proteasome: preparation of
substrates
XBP-1u and XBP-1NT fused to a C-terminal 6XHis tag were
cloned into pIVEX2.3d. BL21 bacteria were transformed with the
vectors and protein expression was induced by IPTG (0.5 mM) for
16 h at 16 C. After resuspension in HEPES 20 mM (pH 7.5) and
sonication, lysates were cleared by centrifugation (10 000g,
10 min, 4 C). Pellets were dissolved in 6 M guanidinium chloride.
Proteins were puriﬁed over Ni+ columns followed by extensive
washing with 1 M NaCl, 20 mM HEPES (pH 7.5), 1% Tween20. Pro-
teins were eluted by 2 M imidazole and dialyzed against 50 mM
HEPES, 50% glycerol. The ﬁnal concentration of XBP-1u was
approximately 100 lg/mL, while for XBP1-DN it was 50 lg/mL.
Purity was 90% (determined by SDS–PAGE).
2.3. Proteasomal degradation reaction conditions and analysis
Proteasomes were puriﬁed as previously described [21]. XBP-1u
and XBP-1NT were incubated at 37 C in HEPES buffer (50 mM
HEPES pH 7.5, 1 mM DTT with or without 0.018% SDS) in the pres-
ence of 20S proteasomes. For degradation by 26S proteasomes, the
proteins were incubated without SDS. For all degradation reactions
the molar ratio of proteasomes to substrates was 1:1000 (1 nM 20S
and 26S proteasomes, 1 lM substrate). Samples from reaction mix-
tures were withdrawn periodically and subjected to immunoblot
analysis with an anti-His tag. The immunoblots were quantiﬁed
using Quantity One program (Bio-Rad).
2.4. LLVY-AMC proteasomal hydrolysis
Puriﬁed 20S proteasomes were incubated at a ﬁnal concentra-
tion of 16 nM with 100 lM ﬂuorogenic 7-amido-4-methylcouma-rin (AMC) tetrapeptide substrates Suc-LLVY-AMC (Bachem) in the
presence and absence of XBP-1NT or XBP-1u (50 nM). AMC ﬂuores-
cence was measured in 96-well plates equilibrated to 37 C. Reac-
tion was terminated after 20 min. Excitation wavelength was
370 nm; emission was recorded at 465 nm.
2.5. On-beads interactions with XBP-1u
XBP-1u and XBP-1NT were cloned into pGEX6p-1 vectors in
frame to GST. Competent BL21 bacteria were transformed with
the vectors and protein expression was induced by IPTG for 4 h
at 37 C. Bacteria were lyzed in STE lysis buffer (NaCl 150 mM, Tris
(pH 8) 10 mM, EDTA 1 mM), which contained 1.5% of sodium lauryl
sarcozine. Following sonication and clearing by centrifugation
(10 000g, 30 min, 4 C) lysates were loaded onto glutathione
beads. Beads were incubated with lysates (90 min, 4 C), washed
three times with TGEM1 buffer (NaCl 1 M, Tris–HCl (pH 7.9)
20 mM, glycerol 20%, EDTA 1 mM, magnesium chloride 5 mM,
NP-40 0.1%) followed by washes with TGEM0.1 buffer (as TGEM1,
except NaCl 0.1 M). Beads were kept at 4 C as 50% v/v suspension
in TGEM0.1 until the experiment.
Proteasome a subunits were cloned into IVEC expression vector.
35S-methionine labeled a subunits were prepared in TNT T7 Cou-
pled Escherichia coli S30 extract system (Promega, WI) according to
manufacturer’s speciﬁcations. For binding assays, protein loaded
beads were blocked for 1 h in room temperature with 1% BSA, fol-
lowed by 2 washes with TGEM0.1. Proteasomes or radiolabeled a
subunits were incubated with the beads for 1 h at 4 C and 1 h at
room temperature. Beads were washed three times with TGEM0.1,
boiled in reduced Laemmli sample buffer and analyzed by Immuno-
blotting. To detect proteasomes, the membranes were incubated
with mouse anti-20S proteasome antibody (Calbiochem, MCP231,
1:15 000), followed by HRP-conjugated goat anti-mouse. Bound a
subunits were detected by SDS–PAGE followed by autoradiography.
2.6. Characterization of XBP-1u degron
XBP-1CTu was cloned in frame into pEGFP-C1. C-terminal trunca-
tions were generated by PCR. Vectors were transfected into 293T
cell. About 24 h after transfection the cells were treated with ZL3VS
(25 lM) for up to 6 h. Equal amounts of cells were harvested at the
indicated time points, lyzed in 1% SDS and proteins were loaded on
SDS–PAGE. The amount of proteins was measured by immunoblot-
ting to GFP using rabbit anti-GFP and to p97 as a loading control.
2.7. Fluorescence microscopy
About 48 h after transfection, 293T cells were treated or not
with ZL3VS (25 lM) for 6 h. Cells were washed in PBS and ﬁxed
in 2% PFA for 10 min at room temperature. After washing with
PBS the cells were permeabilized with 0.25% triton X-100 (7 min,
room temperature), followed by a block with 2% BSA. Cells were
stained with anti-vimentin antibody (clone V9, Golden Bridge
International, WI). Alexa-647 conjugated goat anti-mouse anti-
body (Invitrogen, CA) was used as a secondary antibody. Nuclei
were visualized by Hoechst 33342 staining (0.4 lg/mL, 15 min,
RT, Invitrogen, CA). Images were taken by confocal ﬂuorescence
microscope (Zeiss 410 microscope (PlanApochromat 40)) using
FluView 1000 v.1.5 software.3. Results
3.1. XBP-1u undergoes direct proteasomal degradation
XBP-1u and XBP-1NTwere tagged with 6XHis and expressed in E.
coli. The puriﬁed proteins were incubated with 20S or 26S
Fig. 1. XBP-1u is degraded in vitro by 20S proteasomes. XBP-1u and XBP-1NT were
expressed and puriﬁed. The proteins were incubated with puriﬁed 20S or 26S
proteasomes. (A and B) Degradation of XBP-1NT and XBP-1u by 20S proteasomes in
the presence and absence of SDS; (C) degradation of XBP-1u by 26S proteasomes in
the presence and absence of 2 mM ATP. Shown a typical experiment of three.
A. Navon et al. / FEBS Letters 584 (2010) 67–73 69proteasomes. Low concentrations of SDS were added to facilitate
the opening of the gated a-ring that occludes the entrance to the
catalytic chamber of the 20S proteasome. The levels of the remain-
ing protein were assessed by immunoblotting with anti-His.
20S proteasomes did not degrade XBP-1NT, whether SDS was
added or not (Fig. 1A). In contrast, full-length XBP-1u was readily
degraded by 20S proteasomes in a time-dependent manner (Figs.
1B and S1). Strikingly, SDS was not required to facilitate the degra-
dation of XBP-1u, indicating that XBP-1u may promote directly the
dilation of the gate (Fig. 1B). When 26S proteasomes were used,
degradation of XBP-1u was attenuated (Fig. 1C, notice the different
time scale). Our results indicate the dispensability of ubiquitina-
tion for proteasomal degradation of XBP-1u in vitro.3.2. XBP-1CTu interacts with 20S proteasome
Because XBP-1uwas degraded by the proteasome in the absence
of ubiquitination, we assumed that XBP-1u should physically inter-
act with the proteasomes. GST, GST fused to XBP-1NT (GST-XBP-1NT)
or GST fused to full-length XBP-1u (GST-XBP-1u) were puriﬁed
from the bacterial lysates. A portion was analyzed by SDS–PAGE
and stained with Coomassie blue, while an equivalent portion
was blocked with BSA, washed and incubated with 20S protea-
somes in the presence of ZL3VS. Following the incubation, the beads
were washed and boiled in reducing Laemmli sample buffer. The
presence of the proteasomes was measured by Western blotting.
To demonstrate speciﬁc binding of proteasomes to full-length
XBP-1u, we deliberately loaded the beads with less GST-XBP-1u
than GST-XBP-1NT, as demonstrated by Fig. 2B. Albeit loaded with
less protein, GST-XBP-1u bound more 20S proteasome than GST-
XBP-1NT (Fig. 2A), suggesting that XBP-1CTu mediates the interac-
tion with the proteasome.Since XBP-1u degradation was SDS-independent we wanted to
test whether the interaction with the proteasome facilitates diffu-
sion into the core particle. To this end we used the peptide sub-
strate LLVY-AMC, which is cleaved by the chymotrptic-like site of
the proteasome [22]. Addition of XBP-1u doubled the ﬂuorescent
signal generated by AMC in a proteasome inhibitor-dependent
fashion. XBP-1NT in similar concentrations did not affect proteaso-
mal digestion of LLVY-AMC (Fig. 2C). These results support our
observation that binding of XBP-1u to the proteasome opens the
gate into the catalytic core.
3.3. XBP-1u interacts with several a subunits of the proteasome
To test if XBP-1u recognizes speciﬁc subunits of the protea-
somes, we cloned several of the a subunits and translated them
in vitro. The different in vitro translated reactions were incubated
with beads loaded with GST or GST-XBP-1u. We saw preferential
binding of XBP-1u to subunits a5, a6 and a7.2, while not to a2
and a4. Thus, XBP-1u may have the ability to bind multiple sites
in the a ring of the proteasome (Fig. 2D and E).
3.4. The degron of XBP-1u is spread over its 30–40 C-terminal amino
acids
One of the mechanisms that obviates ubiquitination for prote-
asomal degradation is the existence of an unstructured region, of-
ten located at the C-terminus of proteins [23]. Several structure
prediction algorithms indicated that XBP-1CTu is unstructured.
We therefore decided to examine the degron sequence of XBP-1u
in more details. We generated constructs that express C-terminal
truncations of GFP-XBP-1CTu. All proteins were expressed in the
cytoplasm of 293T cells (not shown). Cells were treated with ZL3VS
and samples were taken immediately before the addition, after 2 h
and after 6 h. Samples were analyzed by SDS–PAGE followed by
immunoblotting with anti-GFP. The accumulation following pro-
teasome inhibition indicated proteasomal degradation. We ob-
served incremental stabilization of the GFP fusion protein, which
was inversely proportional to the size of the truncation (Fig. 3).
Deletion of 40 amino acids completely abolished the degradation.
These results suggest that the degron of XBP-1u is spread over its
30–40 C-terminal amino acids.
3.5. Inhibition of the proteasome promotes the generation of
aggresomes, which contain XBP-1u
Because an unstructured domain resembles intermediate state
in the folding process, which is at high risk for aggregation, we rea-
soned that if not degraded in a timely fashion, XBP-1u may aggre-
gate. To test this possibility we visualized XBP-1 under conditions
of proteasome inhibition. 293T cells were transfected with con-
structs that encode for GFP or GFP-XBP-1CTu, and treated with or
without ZL3VS. We observed that while GFP did not change its
intracellular distribution in response to ZL3VS treatment, GFP-
XBP-1CTu, which localized to the cytoplasm, exhibited perinuclear
aggregation upon ZL3VS treatment. To verify whether XBP-1CTu
partitions into bona ﬁde aggresomes we stained the cells to vimen-
tin, a cytoskeleton element, which typically forms cages around
aggresomes [24]. We observed perfect co-localization of vimentin
and GFP-XBP-1CTu, indicating that indeed upon proteasome inhibi-
tion GFP-XBP-1CTu accumulates in classical aggresomes. We
conclude that XBP-1u degradation aborts its aggregation.4. Discussion
The classical pathway of protein degradation involves their
ubiquitination by a K48-linked polyubiquitin tag, which allows
Fig. 2. XBP-1u interacts with the proteasomes. GST, GST-XBP-1u and GST-XBP-1NT were expressed and puriﬁed. (A) Protein-bound beads were incubated with puriﬁed 20S
proteasomes. Bound proteasomes were detected by immunoblotting with mouse anti-proteasome antibodies. Shown is a typical experiment of three. (B) Equal amounts of
beads used in (A) were boiled in reduced Laemmli sample buffer and analyzed by SDS–PAGE followed by coomassie staining. (C) 20S proteasomes were incubated with LLVY-
7-amido-4-methylcoumarin (AMC) in the presence of puriﬁed XBP-1u or XBP-1NT. About 10 lM of MG132 were added as a control. AMC levels were measured after 20 min
and normalized to control. Shown is the average of four independent experiments with the corresponding standard deviation; (D) GST- or GST-XBP-1u-bound beads were
incubated with in vitro translated a subunits. Following extensive washing bound a proteins were resolved by SDS–PAGE followed by autoradiography. (F) Equal amounts of
beads, as used in (E), were boiled in reduced Laemmli sample buffer and analyzed by SDS–PAGE (15%) followed by coomassie staining. (E) Autoradiograms were quantitated
by phosphoimager. Presented is the ratio between materials bound to GST-XBP-1u and bound to GST (termed ‘‘degree of speciﬁc binding to XBP-1u”).
Fig. 3. The C-terminal 30–40 amino acids contribute to the degradation of XBP-1u. (A) After transfection, 293T cells were treated with proteasome inhibitor for up to 6 h.
Equal number of cells was withdrawn at each time points. Cells were lyzed in reduced Laemmli sample buffer and loaded on SDS–PAGE (12%). Western blotting was
performed with anti-GFP and anti-p97 as a loading control. Sown is a typical experiment out of three. (B) Immublots were quantiﬁed by densitometry using Quantity One
program (Bio-Rad). Presented is the ratio between protein levels at each time point relative to the corresponding time zero (termed ‘‘relative stabilization by proteasome
inhibition”).
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Fig. 4. XBP-1u forms aggresomes upon proteasomal inhibition. (A) 293T cells were transiently transfected with GFP. The cells were treated or not with proteasome inhibitor
for 6 h. Nuclei were stained with Hoechst (blue). Images were taken by confocal microscopy (40). (B) Same as (A), except cells were transfected by GFP-XBP-1CTu. (C) Cells
were transfected with GFP-XBP-1CTu and treated with proteasome inhibitor. Cells were permeabalized and stained for vimentin (red). Cells that exhibit perfect co-localization
between GFP-XBP-1CTu and vimentin are shown by yellow arrows.
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proteasome. Binding to the cap facilitates an ATP-dependent pro-
tein unfolding step, which is coupled with the opening of the a
ring gate in the core particle. Once the gate is open the protein
is threaded into the catalytic chamber for proteolysis. It has be-
come clear that an alternative, ubiquitin-independent route exists
for a subset of proteins, which involves a direct recognition by
the proteasome (for review see [25]). The mode of recognition
by the proteasome, and the mechanisms that control the opening
of the a ring gate are largely unknown for the majority of these
proteolytic reactions.The proteasomal degradation rate of XBP-1u is unusually rapid.
Our previous work suggested that XBP-1u may utilize a degrada-
tion mechanism that circumvents ubiquitination [20]. We demon-
strate that XBP-1u undergoes efﬁcient degradation in vitro by 20S
proteasomes in the absence of ubiquitination. Furthermore, XBP-
1u probably facilitates by itself the opening of the gated a-ring
(Fig. 1). This feature was showed for several other clients of the
ubiquitin-independent degradation pathway, such as p21WAF1/CIP1
and a-synuclein [26,27]. In fact binding of short hydrophobic pep-
tides to the proteasome is sufﬁcient to promote a ring opening
[21]. Interestingly, two hydrophobic regions in the XBP-1u were
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minus, the latter mediates the attachment of XBP-1u to the cyto-
solic phase of the ER membrane [17]. The relevance of these
hydrophobic patches to the proteasomal degradation of XBP-1u
awaits examination.
The C-terminus of XBP-1u interacts with the proteasome
(Fig. 2). Stable interaction with the 20S was demonstrated for sev-
eral of the non-ubiquitin-dependent pathway, such as p21WAF1/CIP1,
Rb, p53 and HIF1a [26,28–30]. For those proteins a single a ring
subunits was found to directly interact with the substrates. Our
preliminary data suggest interaction of XBP-1u with several sub-
units (Fig. 2D), perhaps essential for the unusual accelerated
degradation.
E3 ubiquitin ligases usually recognize a structural element in
their cognate substrate, referred to as a degron. Speciﬁc muta-
tions in the degron often abolish the interaction with the E3
ligase, and confer stabilization. The degron for the ubiquitin-
independent pathway is usually an unstructured region, as
demonstrated for ornithine decarboxylase (ODC) [31], as a path-
way that operates in addition to its 26S proteasome-dependent
degradation [32]. Yoshida et al. mapped the region required for
XBP-1u degradation to its last 53 amino acids [18]. We per-
formed a series of deletions in the unstructured C-terminus of
XBP-1u to rigorously assess the contribution for degradation.
The proteasomal degradation was examined indirectly by looking
at the accumulation in response to proteasomal inhibition. This
approach yielded better reproducible results than cycloheximide
chases. For XBP-1CTu, the shorter the unstructured domain, the
more stable the protein was (Fig. 3). Thus, the existence of an
unstructured domain is not merely an on/off switch for ubiqui-
tin-independent degradation; rather its length controls the
degradation kinetics.
While the efﬁcient degradation of XBP-1u probably does not re-
quire its prior ubiquitination, XBP-1u does exhibit ubiquitination
when overexpressed [20,33]. Therefore, the targeting of XBP-1u
into aggresomes may require ubiquitination (Fig. 4). Whether
ubiquitination of XBP-1u occurs following its interaction with the
proteasome remains to be investigated. Aggregation of XBP-1u
may clinically occur in response to treatment of multiple myeloma
with bortezomib, which simultaneously impairs splicing of XBP-1
mRNA and blocks the proteasome [33]. Whether XBP-1u aggrega-
tion is a factor in bortezomib-induced cell death remains to be
investigated.
The degradation of XBP-1u was implicated to accelerate the re-
moval of XBP-1s and ATF6. It should be emphasized that the for-
mation of a complex between a labile and more stable proteins
does not necessarily imply that both components of the complex
will be destroyed concurrently. As exempliﬁed in the case of NF-
jB/IjB, it is likely that the labile protein will get degraded, while
the stable protein will be spared [34]. Interestingly, the ubiqui-
tin-independent degradation of p21WAF1/CIP1 is also regulated by
physical interaction with cyclin D1. However, this interaction sta-
bilizes p21WAF1/CIP1 rather than promotes its degradation [35]. It
will be therefore important to examine whether the unusual mech-
anism of XBP-1u degradation is required to expedite the degrada-
tion of its interacting partners, a puzzling and uncommon
phenomenon.
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